Shukra Pharmaceuticals Ltd.BSE: SHUKRAPHAR

Shukra Pharmaceuticals Ltd. Press Release Jul 14 2026

· Issued by Shukra Pharmaceuticals Ltd. via BSE India

Filed with BSE · · 2 pages · English

Release

The Board took on record and confirmed that, in accordance with the terms of the aforesaid Special Resolution and the applicable provisions of Chapter V of the SEBI ICDR Regulations, the allottees were required to bring in the differential upfront amount of Rs. 0.39 per Warrant (aggregating to Rs. 18,10,770/-), being the additional amount payable on the upfront 25% (Twenty-Five Per Cent) consideration on account of the re-computation of the issue price from Rs. 34.00 to Rs. 35.56 per Warrant, within fifteen (15) days from the date of passing of the Special Resolution. Further, Two Allottees have also paid the balance 75% (Seventy-Five Per Cent) of the Warrant Issue Price of differential consideration on or before July 13, 2026.

Shukra Pharmaceuticals Ltd. on 6ix

Earlier from Shukra Pharmaceuticals

Later from Shukra Pharmaceuticals

All Shukra Pharmaceuticals news releases